Koprivcic I, Marjanovic K, Matic A, Tolusic Levak M, Lovric I, Pauzar B
Acta Clin Croat. 2022; 61(1):79-85.
PMID: 36398078
PMC: 9616027.
DOI: 10.20471/acc.2022.61.01.10.
Dorraji E, Borgen E, Segura-Pena D, Rawat P, Smorodina E, Dunn C
Cancers (Basel). 2022; 14(19).
PMID: 36230782
PMC: 9563779.
DOI: 10.3390/cancers14194859.
Hsu W, Chen C, Chang Y, Cheng C, TsaI Y, Lin C
J Pers Med. 2021; 11(10).
PMID: 34683150
PMC: 8539542.
DOI: 10.3390/jpm11101009.
Zhou J, Chen C, Liu S, Zhou W, Du J, Jiang Y
Ann Transl Med. 2021; 9(7):549.
PMID: 33987247
PMC: 8105804.
DOI: 10.21037/atm-20-6108.
Sethy C, Goutam K, Nayak D, Pradhan R, Molla S, Chatterjee S
J Cancer Res Clin Oncol. 2019; 146(1):245-259.
PMID: 31617074
DOI: 10.1007/s00432-019-03055-2.
Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25.
Zan L, Chen Q, Zhang L, Li X
Bioengineered. 2019; 10(1):374-382.
PMID: 31431131
PMC: 6738446.
DOI: 10.1080/21655979.2019.1657327.
PROGNOSTIC IMPACT OF LOW ESTROGEN AND PROGESTERONE POSITIVITY IN LUMINAL B (HER2 NEGATIVE) BREAST CANCER.
Rajc J, Frohlich I, Mrcela M, Tomas I, Flam J
Acta Clin Croat. 2019; 57(3):425-433.
PMID: 31168174
PMC: 6536280.
DOI: 10.20471/acc.2018.57.03.04.
Caffeic Acid Versus Caffeic Acid Phenethyl Ester in the Treatment of Breast Cancer MCF-7 Cells: Migration Rate Inhibition.
Kabala-Dzik A, Rzepecka-Stojko A, Kubina R, Wojtyczka R, Buszman E, Stojko J
Integr Cancer Ther. 2018; 17(4):1247-1259.
PMID: 30246565
PMC: 6247537.
DOI: 10.1177/1534735418801521.
Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer.
Liao S, Li J, Yu L, Sun S
J Zhejiang Univ Sci B. 2017; 18(4):334-342.
PMID: 28378571
PMC: 5394098.
DOI: 10.1631/jzus.B1600184.
Brown Seaweed Fucoidan Inhibits Cancer Progression by Dual Regulation of mir-29c/ADAM12 and miR-17-5p/PTEN Axes in Human Breast Cancer Cells.
Wu S, Wu A, Yuan K, Liu S
J Cancer. 2016; 7(15):2408-2419.
PMID: 27994679
PMC: 5166552.
DOI: 10.7150/jca.15703.
Deletion/duplication mutation screening of TP53 gene in patients with transitional cell carcinoma of urinary bladder using multiplex ligation-dependent probe amplification.
Bazrafshani M, Nowshadi P, Shirian S, Daneshbod Y, Nabipour F, Mokhtari M
Cancer Med. 2015; 5(2):145-52.
PMID: 26685928
PMC: 4735784.
DOI: 10.1002/cam4.561.
HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation.
Xu Y, Wang H, Chen F, Guo W, Wang Y, Li H
Oncotarget. 2015; 6(40):42854-67.
PMID: 26536657
PMC: 4767476.
DOI: 10.18632/oncotarget.5733.
Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients.
Ma F, Liu Z, Hu X, Ling H, Li S, Wu J
PLoS One. 2014; 9(10):e111639.
PMID: 25360699
PMC: 4216121.
DOI: 10.1371/journal.pone.0111639.
Dynamic transcription factor activity and networks during ErbB2 breast oncogenesis and targeted therapy.
Weiss M, Penalver Bernabe B, Shin S, Asztalos S, Dubbury S, Mui M
Integr Biol (Camb). 2014; 6(12):1170-82.
PMID: 25303361
PMC: 4237672.
DOI: 10.1039/c4ib00086b.
Gene-environment interactions for breast cancer risk among Chinese women: a report from the Shanghai Breast Cancer Genetics Study.
Li H, Beeghly-Fadiel A, Wen W, Lu W, Gao Y, Xiang Y
Am J Epidemiol. 2012; 177(2):161-70.
PMID: 23221726
PMC: 3590035.
DOI: 10.1093/aje/kws238.
Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease.
Simmons O, Maples P, Senzer N, Nemunaitis J
ISRN Oncol. 2012; 2012:247657.
PMID: 22523703
PMC: 3317005.
DOI: 10.5402/2012/247657.
Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.
Han W, Lo H
Cancer Lett. 2012; 318(2):124-34.
PMID: 22261334
PMC: 3304012.
DOI: 10.1016/j.canlet.2012.01.011.
CUEDC2: an emerging key player in inflammation and tumorigenesis.
Man J, Zhang X
Protein Cell. 2011; 2(9):699-703.
PMID: 21976060
PMC: 4875262.
DOI: 10.1007/s13238-011-1089-z.
G-Protein Inwardly Rectifying Potassium Channel 1 (GIRK1) Knockdown Decreases Beta-Adrenergic, MAP Kinase and Akt Signaling in the MDA-MB-453 Breast Cancer Cell Line.
Hance M, Dhar M, Plummer 3rd H
Breast Cancer (Auckl). 2011; 1:25-34.
PMID: 21655370
PMC: 3091401.
DOI: 10.4137/bcbcr.s629.
Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer.
Pan X, Zhou T, Tai Y, Wang C, Zhao J, Cao Y
Nat Med. 2011; 17(6):708-14.
PMID: 21572428
DOI: 10.1038/nm.2369.
